CatalystWireBeta

Chemring Group

CHG · Main Market · Industrial Goods and Services · mcap £1,460m · 539.5p 3 open situations →

Beta Briefing, track record and signals & risks are not ready for Chemring Group yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation
dots = announcements

Open · 3

Project milestones

Norway second explosives facility

Feasibility study with Norwegian Government under way

Chemring Nobel is working with the Norwegian Government on a second explosives facility; phase two concept selection began in early 2026. This announcement confirms the feasibility study continues alongside Sætre capacity expansion. It also adds a new Chair, Geir Håøy, with Norwegian industrial and political experience, for the scale-up.

Status
Feasibility study with the Norwegian Government on a new production facility
Related work
Significantly expanding capacity at the Sætre site
New Chair
Geir Håøy, former Kongsberg Gruppen CEO, from 1 July 2026
Next milestone
No date stated

Next: Phase two concept selection and feasibility study outcome

  1. 30 Jun 2026 Feasibility study with Norwegian Government under way
  2. 20 Feb 2026 Phase two concept selection under way
Open the full view – chart and every step →
Disposal of a part (break-up)

Alloy Surfaces strategic review

Review outcome: retained, restarting manufacturing

Next: updated guidance on financial profile at the year end; reclassify ASC as continuing

  1. 25 Jun 2026 Review outcome: retained, restarting manufacturing
  2. 2 Jun 2026 Discontinued; £8.1m H1 loss after tax
  3. 9 Dec 2025 Reported as discontinued operation
  4. 10 Nov 2025 Strategic options being assessed; reported as discontinued
Open the full view – chart and every step →
Upgrade / downgrade cycle

UK Government order placement delays

Near-term disruption continues; DIP awaited

Next: Defence Investment Plan publication

  1. 2 Jun 2026 Near-term disruption continues; DIP awaited
  2. 20 Feb 2026 Still disrupted; intake slightly improved recently
  3. 9 Dec 2025 Delays continue; S&I revenue down 18%
  4. 10 Nov 2025 Delays continuing; S&I cover c.47% for FY26
Open the full view – chart and every step →

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note